Working to give more patients the chance of a full and healthy life
Professor Hani Gabra MD PhD FRCPE FRCP
Professor Hani Gabra, co-founder and CSO, is an internationally recognized leader in ovarian cancer and translational medical oncology. He has over 200 publications and over 27,000 citations with an Hirsch Index of 69.
Dr. Paul Blake FRCP
Dr. Paul Blake, co-founder and CEO, has over 30 years drug development and multiple NDA/MAA approvals working for Zeneca (now AZ), SB (now GSK), Cephalon (now Teva), Oxford BioMedica and Heron Therapeutics.